Improved exome prioritization of disease genes through cross-species phenotype comparison.
Improved exome prioritization of disease genes through cross-species phenotype comparison.
复制标题
DOI:
10.1101/gr.160325.113
复制
发表时间:
2014-02
期刊:
影响因子:
7
通讯作者:
Smedley D
中科院分区:
文献类型:
--
作者:
Robinson PN;Köhler S;Oellrich A;Sanger Mouse Genetics Project;Wang K;Mungall CJ;Lewis SE;Washington N;Bauer S;Seelow D;Krawitz P;Gilissen C;Haendel M;Smedley D
Numerous new disease-gene associations have been identified by whole-exome sequencing studies in the last few years. However, many cases remain unsolved due to the sheer number of candidate variants remaining after common filtering strategies such as removing low quality and common variants and those deemed unlikely to be pathogenic. The observation that each of our genomes contains about 100 genuine loss-of-function variants makes identification of the causative mutation problematic when using these strategies alone. We propose using the wealth of genotype to phenotype data that already exists from model organism studies to assess the potential impact of these exome variants. Here, we introduce PHenotypic Interpretation of Variants in Exomes (PHIVE), an algorithm that integrates the calculation of phenotype similarity between human diseases and genetically modified mouse models with evaluation of the variants according to allele frequency, pathogenicity, and mode of inheritance approaches in our Exomiser tool. Large-scale validation of PHIVE analysis using 100,000 exomes containing known mutations demonstrated a substantial improvement (up to 54.1-fold) over purely variant-based (frequency and pathogenicity) methods with the correct gene recalled as the top hit in up to 83% of samples, corresponding to an area under the ROC curve of >95%. We conclude that incorporation of phenotype data can play a vital role in translational bioinformatics and propose that exome sequencing projects should systematically capture clinical phenotypes to take advantage of the strategy presented here.
登录
查看更多内容
DOI:
10.1126/science.1215040
发表时间:
2012-02-17
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
MacArthur DG;Balasubramanian S;Frankish A;Huang N;Morris J;Walter K;Jostins L;Habegger L;Pickrell JK;Montgomery SB;Albers CA;Zhang ZD;Conrad DF;Lunter G;Zheng H;Ayub Q;DePristo MA;Banks E;Hu M;Handsaker RE;Rosenfeld JA;Fromer M;Jin M;Mu XJ;Khurana E;Ye K;Kay M;Saunders GI;Suner MM;Hunt T;Barnes IH;Amid C;Carvalho-Silva DR;Bignell AH;Snow C;Yngvadottir B;Bumpstead S;Cooper DN;Xue Y;Romero IG;1000 Genomes Project Consortium;Wang J;Li Y;Gibbs RA;McCarroll SA;Dermitzakis ET;Pritchard JK;Barrett JC;Harrow J;Hurles ME;Gerstein MB;Tyler-Smith C
通讯作者:
Tyler-Smith C
影响因子:
30.8
作者:
通讯作者:
--
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
3.9
作者:
Amberger, Joanna;Bocchini, Carol;Hamosh, Ada
通讯作者:
Hamosh, Ada
影响因子:
4.3
作者:
Doelken SC;Köhler S;Mungall CJ;Gkoutos GV;Ruef BJ;Smith C;Smedley D;Bauer S;Klopocki E;Schofield PN;Westerfield M;Robinson PN;Lewis SE
通讯作者:
Lewis SE